MedTrace Logo

Tuberculosis Research of INA-RESPOND On Drug Resistance

NCT02758236 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 490

Last updated 2024-05-16

Study results available
· View outcomes & findings →

Summary

This study is a prospective observational cohort study of TB patients who are treated or evaluated at 10 study sites. Patients presenting with cough for 2 weeks or longer with at least one additional TB symptom and a chest X-ray suggestive of TB, will be invited to be enrolled in the study. The signed informed consent will designate their willingness to participate on this study.

Conditions

  • Lung Tuberculosis
  • MDR TB

Interventions

OTHER

No Intervention

No Intervention

Sponsors & Collaborators

  • National Institute of Health Research and Development, Ministry of Health Republic of Indonesia

    collaborator OTHER

  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH

  • Ina-Respond

    lead OTHER

Principal Investigators

  • Dr. dr. Erlina Burhan, SpP(K), MSc · Persahabatan Hospital, Jakarta

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-13
Primary Completion
2018-11-30
Completion
2021-04-26

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02758236 on ClinicalTrials.gov